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Cambodia, in which both Plasmodium vivax and Plasmodium falci-
parum are endemic, has been the focus of numerous malaria-control
interventions, resulting in a marked decline in overall malaria inci-
dence. Despite this decline, the number of P. vivax cases has actually
increased. To understand better the factors underlying this resilience,
we compared the genetic responses of the two species to recent
selective pressures. We sequenced and studied the genomes of 70
P. vivax and 80 P. falciparum isolates collected between 2009 and
2013. We found that although P. falciparum has undergone popula-
tion fracturing, the coendemic P. vivax population has grown undis-
rupted, resulting in a larger effective population size, no discernable
population structure, and frequent multiclonal infections. Signatures
of selection suggest recent, species-specific evolutionary differences.
Particularly, in contrast to P. falciparum, P. vivax transcription factors,
chromatin modifiers, and histone deacetylases have undergone
strong directional selection, including a particularly strong selective
sweep at an AP2 transcription factor. Together, our findings point
to different population-level adaptive mechanisms used by P. vivax
and P. falciparum parasites. Although population substructuring in
P. falciparum has resulted in clonal outgrowths of resistant parasites,
P. vivax may use a nuanced transcriptional regulatory approach to
population maintenance, enabling it to preserve a larger, more diverse
population better suited to facing selective threats. We conclude that
transcriptional control may underlie P. vivax’s resilience to malaria con-
trol measures. Novel strategies to target such processes are likely re-
quired to eradicate P. vivax and achieve malaria elimination.
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During the last decade, western Cambodia has been the focusof numerous and multimodal interventions to control the
spread of artemisinin-resistant Plasmodium falciparum (1, 2).
Such interventions, including increased vector control, increased
surveillance, and improved access to quality artemisinin-combi-
nation therapy (ACT), would be expected to curtail coendemic
Plasmodium vivax as well. However, even as P. falciparum in-
fections in Cambodia decreased by 81% between 2009 and 2013,
P. vivax cases have increased, making it the predominant species
in the Mekong region (3–6). This scenario, repeated in Brazil and
other areas of coendemicity, has led to growing awareness that
P. vivax, although infecting the same populations and transmitted
by the same mosquito vectors, will likely be the more challenging
species to eradicate (6–9). In this study, we use population ge-
nomics to gain insight into the evolutionary factors underlying
P. vivax’s resilience to malaria control measures.
Population genetic studies have previously hinted at the resil-
ience of P. vivax populations in comparison with P. falciparum.
Studies of microsatellites and highly variable antigens of sympatric
P. vivax and P. falciparum populations in Southeast Asia and the
Southwest Pacific have consistently shown P. vivax populations to be
more diverse, with a higher effective population size (Neff), more
stable transmission, and increased gene flow between geographic
islands, whereas P. falciparum populations tend to be clonal with
episodic transmission and structure-by-geography (10–15). We hy-
pothesized that the species have evolved disparate responses to se-
lective pressures and that genomic studies of sympatric Plasmodium
sp. populations would highlight key differences in their population
structures, demographic histories, and genomic selective signatures,
helping elucidate the basis for these observed differences.
To understand the genome-wide species-specific patterns of
selection in sympatric P. vivax (n = 70) and P. falciparum (n = 80)
populations in Cambodia, we conducted whole-genome sequenc-
ing of coendemic parasites sampled between 2009 and 2013 at a
primary site and two satellite sites in western Cambodia (Fig. S1).
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These sites were designated as “zone 2” during the recent artemisinin-
resistance containment campaign and as such were subject to
intensified malaria control efforts (16). We initially assessed the
relative diversity, within-host complexity, population structure, and
demographic histories of the two parasite populations, finding that
the P. vivax population remains less structured, more diverse, and
more rapidly expanding than the sympatric P. falciparum pop-
ulation. We then evaluated genome-wide signatures of selection in
both populations using haplotype-based tests of directional selec-
tion, allele frequency-based tests of selection, and copy-number
analysis. Differences in genomic loci under directional selection in
the two populations highlight different mechanistic responses to
selective pressures, suggesting that more nuanced transcriptional
control may underlie the resilience of the P. vivax population.
Results
Sequencing Sympatric P. vivax and P. falciparum Populations.Whole-
genome sequencing identified 61,448 high-quality P. vivax SNPs
and 6,734 P. falciparum SNPs from 70 and 80 samples, respec-
tively. All P. vivax isolates had fivefold or greater coverage in
≥99% of coding regions, whereas all P. falciparum isolates had
fivefold or greater coverage in ≥94% of coding regions. Addi-
tional information about sequence quality and coverage is pro-
vided in SI Materials and Methods, SI Sequencing Sympatric
P. vivax and P. falciparum Populations.
P. vivax Infections Have Higher Within-Host Diversity than Sympatric
P. falciparum Infections. Because Plasmodia infections are fre-
quently multiclonal, we investigated the extent of multiclonality
among our sequenced field isolates. When applied to whole-
genome sequencing data, the FWS statistic accurately predicts
polyclonality (17). P. vivax infections were more polyclonal (de-
fined as FWS <0.95) than P. falciparum infections (P < 0.0001;
Fisher’s exact test), a finding that remained unchanged after
bootstrapping to account for the difference in the number of
SNPs identified in the two species (Fig. 1A). Using the accepted
standard of FWS <0.95 as the marker of a multiclonal infection,
60% of P. vivax isolates and 22.5% of P. falciparum isolates in
our cohort were polyclonal (Fig. 1B). To confirm the reliability
of this method for identifying polyclonal infections, we con-
ducted amplicon deep sequencing of P. vivax merozoite surface
protein 1 (pvmsp1) in 47 isolates, finding a high degree of
agreement with FWS (SI Materials and Methods, SI P. vivax In-
fections Have Higher Within-Host Diversity than Sympatric P. fal-
ciparum Infections) (18). Subsequently, most analyses were
performed both for the 28 P. vivax infections that were mono-
clonal by the FWS metric and for all P. vivax samples (i.e., mul-
ticlonal and monoclonal infections) to assess the effect of
multiclonality on our results.
P. vivax Has Less Population Substructuring than Sympatric P. falciparum.
Principal component analysis (PCA) revealed no population sub-
structuring among P. vivax isolates. In contrast, P. falciparum para-
sites were partitioned into subpopulations (Fig. 2). These partitions
did not correspond to collection site, date of collection, or multi-
plicity of infection (MOI). We used k-means clustering to confirm
that all P. vivax isolates were part of a single cluster and that the
P. falciparum population was subdivided into four clusters (Fig.
S2) (19). One cluster represents a central “ancestral-like”
P. falciparum population from which subpopulations of drug-
resistant parasites have undergone epidemic expansion.
Analysis of additional projections supports these differences in
population structure (Fig. S3). Therefore most analyses were per-
formed using all P. falciparum samples and, separately, using the 18
parasites of the central ancestral-like population.
P. vivax Has Undergone More Rapid Expansion than Sympatric P. falciparum.
To explore the differences in demographic histories, we examined
the allele-frequency spectra (AFS) of the P. vivax and P. falciparum
populations. Spectra were calculated by variant type and compared
with the spectrum expected in a simulated coalescent population
with no natural selection, constant population size, and complete
random mating (Fig. 3). We observed an excess of low-frequency
derived alleles in the Cambodian P. vivax AFS [both for the entire
sample and for the monoclonal infections only (Fig. 3 and Fig. S4)],
suggesting population expansion. In contrast, the overall P. falci-
parum population had no excess of low-frequency alleles, suggesting
limited or absent population expansion. However the overall
P. falciparum population did exhibit an excess of intermediate-
frequency derived alleles, which likely reflected the presence of
multiple P. falciparum subpopulations and which disappeared
upon analysis of only the central, ancestral-like population (Fig. 3
and Fig. S4).
Next, we fit various demographic scenarios to the observed
allele-frequency spectra to identify a best-fit model and specific
population parameters. Using a diffusion approximation para-
digm, we tested scenarios of constant population size, population
decline, exponential increase, two-epoch increase, and bottleneck
with subsequent exponential growth (Fig. 4) (20). We used the
Akaike information criterion (AIC) to inform model selection.
For P. vivax (all samples and monoclonals only), models of par-
asite expansion strongly outperformed the other models, with the
Fig. 1. Higher MOI in P. vivax infections compared with P. falciparum infections. (A) FWS calculated for P. vivax and P. falciparum. Points represent the point
estimate of FWS for each sample in the respective population. Vertical bars represent the maximum and minimum value in 1,000 bootstrap replicates, which
downsampled the number of SNPs to be equal for P. vivax and P. falciparum, to correct for the increased number of P. vivax SNPs. (B) Summary bar graph
representing the number of P. vivax (Pv) and P. falciparum (Pf) clinical isolates considered monoclonal or polyclonal, with a cutoff of FWS <0.95 being
considered polyclonal.












model of positive exponential growth having the best fit (Table
S1). For the ancestral-like P. falciparum population, exponential
growth models marginally outperformed the other models, suggest-
ing only modest expansion of this parasite population (Table S2).
Comparison of best-fit models suggests that P. vivax has expanded
more dramatically [factor of population contraction (ηG) = 20.00]
and over a short time span (T = 1.03) than the ancestral-like
P. falciparum population (ηG = 1.94, T = 4.99), resulting in a larger
Neff for P. vivax than for P. falciparum [ancestral mutation rate (θ) =
850 and 240, respectively] (Tables S1 and S2).
To assess the goodness-of-fit of these inferred parameters, we
selected the best-fit models to parameterize coalescent simula-
tions. Tajima’s D was calculated for each simulated gene and
compared with observed values of Tajima’s D (Fig. S5). Simu-
lated and observed values of Tajima’s D for P. vivax and P. fal-
ciparum were concordant, with a negative mean value and a
strong right skew, supporting the inferred population histories
for both P. vivax and P. falciparum (Fig. S6). Cell-surface pro-
teins in P. falciparum have been described previously as being
under strong balancing selection (high Tajima’s D) because of
selection by human immunity. Our analysis confirmed enrich-
ment for cell-surface protein exons among targets of strong
balancing selection after Bonferroni correction (P = 0.00124)
(Table 1). Genome-wide assessment of balancing selection with
Tajima’s D for P. vivax has not been reported previously, and we
found several instances of modest Gene Ontology (GO)-term
enrichment among targets of strong balancing selection, in-
cluding chromatin modifiers (Table 1). Additional details about
the assessment of Tajima’s D are provided in SI Materials and
Methods, SI Assessment of Tajima’s D.
P. vivax Shows Stronger Evidence of Recent Directional Selection on
Transcriptional Regulators than P. falciparum.The population structure
of P. falciparum in Cambodia has been shaped by the intensive use
of artemisinins and their partner drugs, bed nets, and improved
diagnostics (21, 22). However, little is known about how coendemic
P. vivax populations have responded to these same selective forces.
We used linkage disequilibrium-based tests to identify genomic
regions that have undergone recent directional selection consistent
with selective sweeps. Because these tests are haplotype based,
we focused on the monoclonal P. vivax isolates (n = 28) and the
Fig. 2. PCA reveals striking differences in population structure between Cambodian P. vivax and P. falciparum. PCA was performed from single-nucleotide genetic
variant data for each of 70 P. vivax clinical isolates (A) and 80 P. falciparum clinical isolates (B). Monoclonal P. vivax isolates are shaded dark gray. Among P. falciparum
isolates, members of the ancestral-like population are shaded dark gray. Noise was added to the P. falciparum panel to mitigate overplotting.
Fig. 3. Allele-frequency spectra suggest greater population expansion among P. vivax than among P. falciparum. Each column indicates the fraction of the
total SNPs that fall into a particular frequency class. Columns are color coded by type of SNP. The x axis represents the number of samples within which each
SNP occurs. (Upper) We observed a preponderance of low-frequency alleles in the P. vivax population, compared with coalescent simulations of a no-growth
population (black line). Under a Wright–Fisher model of genetic evolution, these data suggest that the P. vivax population has undergone a recent expansion.
(Lower) In contrast, for P. falciparum, we observed an excess in intermediate-frequency minor alleles, reflecting the subdivided population structure.
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ancestral-like P. falciparum group (n = 18), which were predomi-
nantly monoclonal (15/18).
Using 45,701 high-quality SNPs occurring in the monoclonal
P. vivax infections, we performed the nSL test for directional
selection (23). This haplotype-based testing offers the advantage
of not requiring a genome recombination map and has proven
sensitive for detecting incomplete selective sweeps. Strikingly,
among the 15 strongest signals of directional selection, six
were in close proximity to regulators of gene expression (four AP2
domain-containing transcription factors and two proteins containing
the SET domain, which is a histone modulator) (Fig. 5A and Table
2). The strongest signal was on chromosome 14, in close proximity
to an AP2 domain-containing transcription factor (PVX_122680).
Analysis of the entire P. vivax population using nSL yielded quali-
tatively similar, although blunted, results because of the artifactual
breakdown of linkage disequilibrium caused by multiple infections
(Fig. S7). Similar results were found when the integrated haplotype
score (iHS), which has been used extensively in malaria studies to
assess directional selection, was calculated for these same loci (Fig.
S7). In contrast, when nSL testing was performed for the 5,158 SNPs
in the P. falciparum ancestral-like population, only a single tran-
scription factor was identified as being under moderate directional
selection (Table 3 and Fig. S7). This difference does not appear to
be attributable to the smaller number of SNPs used in the
P. falciparum analysis (likely resulting from a more clonal population
as well as from a decreased ability to call SNPs in intergenic regions
of the AT-rich P. falciparum genome). As evidence that results are
not significantly impacted by detection bias between genic and
intergenic SNPs, when we repeated nSL testing in the P. vivax
population using only the 28,746 genic SNPs, no appreciable dif-
ferences in nSL signals were identified. The high level of coverage
achieved in the coding regions of both populations suggests an equal
opportunity to detect signatures of selection among transcription
factors in both species.
To determine the extent of haplotype homozygosity around
the predominant selective sweep, we performed extended hap-
lotype homozygosity (EHH) testing, centering our analysis on the
SNP with the highest nSL score. We identified a 100-kb region of
strong linkage disequilibrium around the principle chromosome
14 locus (Fig. 5 B and C) in isolates with the selected allele. In our
Cambodian P. vivax population sample, this ApiAP2 transcription
factor contains 25 polymorphisms (Table S3), including two high-
frequency nonsynonymous changes, one of which occurs within
the AP2 DNA-binding domain, based on comparisons with its
Fig. 4. Five one-population models were used for demographic inference. The following models were fitted to observed P. vivax and P. falciparum allele-
frequency spectra using a diffusion approximation of population evolution: (A) a model of no change in Neff through time; (B) a model of population decline
beginning at time T; (C) a model of exponential population expansion, beginning at time T; (D) a two-epoch model of sudden population expansion at time T;
(E) a model of rapid population decline followed by exponential growth, beginning at time T. In all cases, the exponential-growth model (C) was at least
marginally the best fit scenario. For the P. vivax population, growth models (C–E) far outperformed the static (A) or decline (B) models. See Tables S1 and S2.
Table 1. GO analysis of observed Tajima’s D values uncovers evidence for enrichment of GO terms in genes under
strong directional and balancing selection
Dataset* Feature† D percentile‡ GO term GO ID P value§
P. vivax (M/A) Exon First Histone deacetylase complex GO:0000118 0.0423
P. vivax (M) Gene First ATP binding GO:0005524 0.0493
P. vivax (A) Gene First Cellular component GO:0005575 0.00941
P. vivax (M) Exon 99th Metallo-sulfur cluster assembly GO:0031163 0.0440
P. vivax (M) Exon 99th Iron-sulfur cluster assembly GO:0016226 0.04402
P. vivax (M/A) Gene/exon 99th Plastid large ribosomal subunit GO:0000311 0.0166
P. vivax (M/A) Gene/exon 99th Plastid ribosome GO:0009547 0.0306
P. vivax (M/A) Gene/exon 99th Plastid part GO:0044435 0.0306
P. vivax (M/A) Gene/exon 99th Plastid stroma GO:0009532 0.0306
P. falciparum Gene First Retrograde transport, endosome to Golgi GO:0042147 0.0431
P. falciparum Gene First Endosomal transport GO:0016197 0.0431
P. falciparum Gene/exon 99th Cell surface GO:0009986 0.00124
Tajima’s Dwas calculated on a per-gene and per-exon basis for the entire P. vivax population sample, the P. vivaxmonoclonal subset,
and the central, ancestral-like P. falciparum subpopulation. For genewise and exonwise Tajima’s D values, the first percentile (largest
negative values) and 99th percentile (largest positive values) were included in GO term enrichment analysis.
*(M) indicates the result was found among P. vivax monoclonals; (A) indicates result found among the entire P. vivax population
sample.
†GO-term enrichment was found in exonwise analysis, genewise analysis, or both exon- and genewise analyses.
‡First percentile indicates largest negative Tajima’s D values, consistent with directional selection; 99th percentile indicates largest
positive Tajima’s D values, consistent with balancing selection.
§Bonferroni-corrected P values; if a term was significant (to a Bonferroni-corrected P ≤ 0.05) in both monoclonal (M) and all (A)
analyses, the more conservative (higher) of the two P values is reported.












P. falciparum ortholog (PF3D7_1317200) (24). In addition to the
AP2-domain transcription factor, this region contains 25 genes
(Table S4).
We found complementary evidence that P. vivax transcriptional
regulators are under strong directional selection using allele fre-
quency-based testing for selection. We calculated genewise Tajima’s
D (an allele frequency-based test, in contrast to nSL and iHS, which
are haplotype-based tests of selection) for P. vivax and P. falciparum.
We selected the first and 99th percentile of observed genewise
Tajima’s D values and investigated these genes for functional en-
richment. We observed enrichment of histone deacetylase complex
members among the first percentile of genes, but this observation
did not reach significance after Bonferroni correction. Because
strong local values of Tajima’s D can be obscured when considering
an entire gene, we also performed this analysis in an exonwise
manner for both P. vivax and P. falciparum (18). In this way we
found statistically significant enrichment for histone deacetylase
complex members among the first-percentile exons after strict
Bonferroni correction (P = 0.0423) (Table 1).
Both P. vivax and P. falciparum Show Evidence of Recent Directional
Selection on Known and Putative Drug-Resistance Genes. Four of the
strongest 15 strongest nSL signals in P. vivax were in close proximity
to transporters (pvmdr1, pvmdr2, pvmrp1, and an ABC transporter),
all of which are potential drug-resistance loci (Table 2). A prom-
inent sweep did encompass the pvmdr1 locus. We compared key
drug-resistance SNP frequencies in pvmdr1 to frequencies in
Cambodian isolates collected several years earlier, during 2006 and
2007, from Kâmpôt province (25). Two key mutations (Y976F and
F1076L) existed at roughly the same frequency (89% in previously
Fig. 5. Evidence for strong selective sweeps in Cambodian P. vivax. (A) A Manhattan plot of normalized nSL values. Each point corresponds to an SNP, and the
top 0.5% values (under strong directional selection) are rendered in orange. Polymorphisms without evidence of strong directional selection are rendered in
either gray or green, according to chromosome. This view suggests that several genomic regions are under positive selection, including areas near tran-
scription factors (AP2 domain-containing), chromatin regulators (SET10 and HP1), antigens under known positive selection (SERA4 and 5), and drug-resistance
genes (MDR1 and MRP1). (B and C) The extent of EHH in the strongest sweep, within chromosome 14 in A. (B) EHH decay for the haplotypes around selected
(orange) and unselected (green) alleles. (C) A haplotype bifurcation diagram is shown centered on the focal variant. Line thickness represents the number of
identical haplotypes flanking the selected (orange) or unselected (green) alleles. Linkage breaks down with increasing distance from the focal variant. B and C
provide evidence that the strong sweep on chromosome 14 extends ∼50 kb in each direction.
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collected samples vs. 77% in more recently collected samples and
87% in previously collected samples vs. 90% in more recently col-
lected samples, respectively). This high similarity in allele frequency
in samples collected before and during the artemisinin-resistance
containment efforts suggests that the sweep encompassing the
pvmdr1 locus was not driven by ACT drug pressure or resistance-
containment efforts and may result from more longstanding chlo-
roquine pressure (similar to pfmdr1mutations in P. falciparum) that
preceded containment efforts. Allele frequencies for all polymor-
phisms in known or putative drug-resistance genes are summarized
in Table S5.
Similar to previous studies of directional selection in P. falci-
parum, we identified drug-resistance genes (e.g., pfcrt and kelch
K13) with evidence of strong directional selection (Table 3) (26–
29). Allele frequencies for all polymorphisms in known drug-
resistance genes are summarized in Table S6. Of note, both nSL
and iHS statistics revealed a chromosome 11 locus with strong
and extended directional selection (Table 3 and Fig. S7). This locus
encompassed the pfama1 and phosphatidylinositol-4-phosphate
5-kinase genes (PF3D7_1129600). Interestingly, PF3D7_1129600
catalyzes the phosphorylation of phosphatidylinositol 4-phosphate
to form phosphatidylinositol 4,5-bisphosphate (30). The drug target
PI(4)K (PF3D7_0509800) alters the intracellular distribution
of phosphatidylinositol-4-phosphate in the parasite, placing
these genes on the same biologic pathway (31). Although the
functional significance of this signal is unclear, genome scans in
other populations also have identified strong directional se-
lection at this locus (27, 32).
Copy-Number Variants Are Not Associated with Detected Selective
Sweeps. Copy-number variants (CNVs) are important in the
evolution of parasite populations (33). Using two complementary
Table 2. Top hits in nSL analysis of P. vivax monoclonal infections
Chr
Focal SNP statistics Sweep region statistics
Location nSL Closest plausible genetic driver Gene ID Distance*
14 797,870 6.203 Transcription factor with AP2 domain(s), putative (apiap2) PVX_122680 −4,462
10 351,691 4.453 Multidrug resistance protein 1, putative (MDR1) PVX_080100 10,010
14 1,650,897 4.389 Heterochromatin protein 1 (HP1); H3 lysine methyltransferase (SET10) PVX_123682; PVX_123685 999; 9,918
04 577,543 4.215 Serine-repeat antigen 4 (SERA) PVX_003825; PVX_003830 789; −1,691
Serine-repeat antigen 5 (SERA)
02 85,446 3.997 Multidrug resistance-associated protein 1, putative (MRP1) PVX_097025 −68,196
03 368,737 3.964 Hypothetical proteins — —
13 396,427 3.805 ABC transporter B family member 7, putative (ABCB7) PVX_084521 −7,326
11 1,900,445 3.581 Transcription factor with AP2 domain(s), putative (apiap2) PVX_113370 −31,184
12 2,421,187 3.578 Multidrug resistance protein 2 (MDR2) PVX_118100 −4,361
11 749,030 3.549 SET domain containing protein PVX_114585 46,877
09 1,693,066 3.527 Transcription factor with AP2 domain(s), putative (AP2-O) PVX_092760 7,201
14 1,002,439 3.515 Hypothetical proteins — —
09 1,506,397 3.403 Transcription factor with AP2 domain(s), putative (apiap2) PVX_092570 9,327
13 676,297 3.393 Hypothetical protein — —
05 1,303,321 3.299 Vir and fam antigens — —
Haplotype-based tests of selection were performed in monoclonal samples to avoid false breakdown of linkage caused by mixed genotypes from
sequencing. Results are presented by ranking on absolute normalized nSL score.
*Distance in bases from focal SNP to the putative driver gene; a negative sign indicates putative driver gene occurs upstream of the focal SNP.
Table 3. Top hits in nSL analysis of P. falciparum ancestral-like population
Chr
Focal SNP statistics Sweep region statistics
Location nSL Closest plausible genetic driver Gene ID Distance*
04 531,138 3.220 Hypothetical proteins — —
07 384,302 3.106 Chloroquine resistance transporter (CRT) PF3D7_0709000 18,920
11 1,089,187–1,347,798 3.024 Phosphatidylinositol-4-phosphate 5-kinase; apical
membrane antigen 1 (AMA1)
PF3D7_1129600; PF3D7_1133400 51,935; −93,151
13 2,550,178 2.924 Hypothetical proteins — —
06 1,093,476 2.871 Hypothetical proteins — —
14 610,371 2.805 Hypothetical proteins — —
06 825,473 2.730 Merozoite surface protein 10 (MSP10) PF3D7_0620400 −25,905
09 203,308 2.656 Hypothetical proteins — —
12 124,649 2.652 Dynein heavy chain, putative PF3D7_1202300 0
13 639,213 2.597 Transcription factor MYB1 (MYB1) PF3D7_1315800 −20,805
02 374,197 2.589 Serine repeat antigen 1 (SERA1) PF3D7_0208000 48,474
03 361,403 2.571 Hypothetical proteins — —
13 1,775,996 2.563 Kelch protein K13 (K13) PF3D7_1343700 48,999
01 226,924 2.505 Hypothetical proteins — —
09 513,729 2.489 Cysteine repeat modular protein 1 (CRMP1) PF3D7_0912000 0
Results are presented by ranking on absolute normalized nSL score.
*Distance in bases from focal SNP to the putative driver gene; a negative sign indicates putative driver gene occurs upstream of the focal SNP; a zero indicates
focal SNP occurs within the putative driver gene.












in silico methods, we identified a handful of high-confidence
CNVs in the P. vivax and P. falciparum populations (Table S7).
Notably, we identified Duffy-binding protein (DBP) duplication
events in 17 of 70 P. vivax isolates and multidrug-resistance
protein 1 (MDR1) duplication events in 12 of 80 P. falciparum
isolates. As in previous work in P. falciparum (33), no high-
confidence CNV occurred in close proximity with the selective
sweeps identified above.
Discussion
In this study we compared whole-genome sequence data of 70
P. vivax and 80 coendemic P. falciparum infections to show that the
P. vivax population in western Cambodia has experienced more
rapid and uninterrupted growth than the sympatric P. falciparum
population, resulting in less substructuring and a larger Neff.
Clues to the causes underlying this population-level resilience of
P. vivax in the face of malaria-control measures can be found in
the different genomic signatures of selection between the two
species. Evidence for the importance of transcriptional regula-
tion to the success of P. vivax was found both by haplotype-based
and allele frequency-based tests of selection. Although known
and putative drug-resistance genes were found at the center of
selective sweeps in both P. falciparum and P. vivax in this and
other studies (Tables 2 and 3), the strongest selective sweep in
the P. vivax population occurred in close proximity to an AP2
transcription factor (PVX_122680), suggesting that P. vivax is
responding to selective pressures by altering its transcriptional
profile (29, 34, 35).
Although studies of transcriptional regulation in P. vivax are
just beginning (36–38), some of the key biological processes that
are thought to help P. vivax evade traditional control measures
may be under tight transcriptional control. Unlike P. falciparum,
P. vivax gametocytogenesis occurs early and concomitantly with the
asexual cycle, so by the time a person is symptomatic or is diagnosed
with P. vivax malaria, that person already harbors infectious ga-
metocytes capable of infecting mosquitoes (39). It appears that a
key step in Plasmodium gametocytogenesis is accomplished by
transcriptional repression via an AP2 family transcription factor that
blocks asexual replication and promotes conversion to the sexual
stage (40). In fact, the P. falciparum ortholog of the principal AP2
gene identified in our study has been associated with transcriptional
regulation of gametocytogenesis (41). Similarly, processes governing
hypnozoite dormancy and activation that underlie P. vivax relapse
may be under epigenetic regulation. Histone deacetylase inhibitors
accelerated the rate of hypnozoite activation in long-term primary
simian hepatocyte cultures, suggesting that histone methylation may
maintain hypnozoite dormancy by suppressing transcription (42,
43). Finally, P. vivax chloroquine resistance has not been found to
correlate with DNA changes in pvcrt but may correlate with the
expression of this transporter protein, whose ortholog mediates
chloroquine resistance in P. falciparum (44–46).
Thus, an ability to modulate transcriptional regulation may be
more central to P. vivax’s adaptation to selective pressures than for
P. falciparum. Notably, a previous comparison of a 1990s era Peru-
vian P. vivax isolate to the reference Sal1 strain collected 35 y earlier
found an increased dN/dS signal at two AP2-containing transcription
factors, suggesting that evolutionary changes in these genes are not
confined to P. vivax in Cambodia (47). Because this was a within-
species comparison of nonsynonymous to synonymous SNP ratio
(dN/dS), it is difficult to determine the time-scale (e.g., whether
ancient or recent) associated with this selection (48). The top hit in
our selective sweep, a sign of recent and strong directional selection,
was an AP2 factor that was specifically cited among genes with >1.0
dN/dS in this previous study.
The potential reliance on transcriptional changes is not an ab-
solute difference between species, however. CNV of pfmdr1, which
likely leads to increased gene transcription, is known to modulate
drug efficacy. However, a closer look at previously published
P. falciparum scans for selection in multiple locations in Africa
also reveals a role for adaptation through the modification of
transcriptional regulation. The P. falciparum ortholog of the SET-
domain protein on chromosome 11 (PVX_114585) identified in
our nSL analysis lies near the center of a selective sweep that also
has occurred in Senegal, the Gambia, and Ghana (16, 49, 50). In
addition, it is known that transcriptional timing can affect
P. falciparum drug-resistance responses, in particular to arte-
misinins (51). These findings suggest an underappreciated role
for the modification of transcriptional regulation in P. falciparum
fitness.
Further investigation of the potential role of transcriptional mod-
ification in P. vivax drug resistance and other biological processes will
require continued development of in vitro models. Such research
strategies include modifications to Plasmodium knowlesi homologs,
the use of humanized mice infected with transgenic P. vivax, allowing
transcriptional analysis through the liver stage, and the use of mon-
keys infected with transgenic P. vivax, allowing transcriptional
analysis through the blood stage (52–56). To date, descriptions
of transcriptional modification in Plasmodium sp. appear to be
limited to associations with genomic structural variants, for ex-
ample, gene amplification as in pfmdr1 and deletions or repeat-
length polymorphisms in promoter regions (57, 58). One could
hypothesize that SNPs in an AP2 transcription factor DNA-
binding domain may alter its motif binding and stage-specific
expression of downstream genes. More likely, we have not iden-
tified causal variants; rather, our selective sweep is detecting
variants that are in linkage disequilibrium with the true functional
variants, which could be larger deletions or insertions not readily
detected by short-read sequencing. If the selected variants found
in our analyses are replicated in other cohorts, further in vitro
experimentation is needed to determine whether they associate
with transcriptional regulation. Such findings would provide key
evidence of an advanced parasitic response to selective pressure
in P. vivax. They also would suggest that tracking genetically fit
parasites could be complicated, supporting the idea that P. vivax
will be the more challenging species to eliminate.
Our findings of a diverse P. vivax population without a discernible
population structure are similar to microsatellite- and gene-based
studies in Papua New Guinea, Indonesia, Venezuela, and Cambo-
dia that have observed more genetic structuring among P. falciparum
populations than among coendemic P. vivax populations (Fig. 2)
(10–15). We also have previously characterized the within-host di-
versity of coendemic P. vivax and P. falciparum in this region by
amplicon deep sequencing, with results supporting the difference in
polyclonality (59, 60). The high proportion of polyclonal P. vivax
infections and the lack of parasite substructuring also were observed
in a recent report from Cambodia that used deep sequencing of
more than 100 SNPs across the P. vivax genome (18, 61).
Whole-genome sequencing allowed us to extend beyond de-
scriptions of diversity and to make inferences about the demo-
graphic history of sympatric Plasmodium in the region. The best-fit
demographic models indicated that P. vivax in western Cambodia
has undergone steady exponential growth, expanding more rapidly
than the ancestral-like P. falciparum population, for which expo-
nential growth was only marginally the best-fit model (Tables S1
and S2). The demography-adjusted estimate of the ancestral mu-
tation rate (θ), a proxy for Neff, found that the P. vivax Neff is
substantially larger than the ancestral-like P. falciparum population.
These demographic scenarios match epidemiological observations
that P. vivax cases have increased even while P. falciparum incidence
has rapidly declined over the same time period (6). Interestingly,
although the total number of P. falciparum cases in Cambodia has
decreased, our demographic models show a slowly increasing Neff,
at least for the ancestral-like population. Although it is possible that
our models are detecting ancient rather than recent trends, another
study of isolates in this area reached similar conclusions, lending
credence to our findings and suggesting that recent control efforts
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have not significantly decreased P. falciparum genetic diversity in
the region (62).
We should note that we have largely assumed that selective
pressures have been imposed by human control interventions,
primarily antimalarial treatment. However, we cannot rule out
the possibility that other selective pressures have also affected par-
asite population structuring, for example, widespread deforestation
and climate change altering the diversity of Anopheline vec-
tors or evolving host–parasite interactions within mosquito
vectors. In P. vivax, a strong New World vs. Old World divide
correlates with genetic variation in pvs47, the ortholog of pfs47,
which has been associated with differential infectivity in different
mosquito species (63, 64). However, both Anopheles dirus s.s. and
Anopheles minimus s.s., the main malaria vectors in Cambodia, are
adept at transmitting both P. falciparum and P. vivax (65, 66).
Therefore we do not think that the species-specific differences ob-
served in population structure and signatures of selection are at-
tributable solely to unmeasured mosquito factors.
Finally, the population structuring we observed among con-
temporary Cambodian P. vivax and P. falciparum isolates should
be interpreted in light of their ancient demographic histories
(67). Evidence has shown that both species of malaria are sig-
nificantly less diverse than primate malarias and likely have
undergone genetic bottlenecks associated with host switching
and emergence out of Africa, likely less than 10,000 y ago (63,
68–72). As these species have emerged from the bottleneck, they
likely have undergone both sustained and recent selection. In the
case of P. vivax, previous work has demonstrated that long-term
diversifying and directional selection has shaped its genetic diversity
(63, 68). Our data are consistent with this finding, showing minimal
structuring in the P. vivax population but evidence of strong di-
rectional selection in multiple regions of the genome. Additional
investigation is required to determine if these adaptive signatures
are geographically restricted (68) or occurred as or before P. vivax
expanded out of Africa. In the case of P. falciparum, reductions in
diversity immediately around loci associated with drug resistance
(73, 74) are commonly reported, and the current substructuring
seen in Cambodian P. falciparum parasites has been linked to drug-
resistant subtypes (22). This evidence suggests that more recent
selective forces have shaped population structure in this species.
Previous studies also suggest that P. falciparum infections in
Southeast Asia were more multiclonal two decades ago, again
suggesting that recent forces have constrained its genetic di-
versification (75–77). This evidence is consistent with our findings
that P. falciparum in Cambodia has undergone large demographic
shifts much more recently than P. vivax.
Applying population genomic tools to Plasmodium parasites
comes with caveats. Malaria parasites have a complex lifecycle,
including human and mosquito stages, with multiple clonal
generations occurring within the human bloodstream and fre-
quent bottlenecks during transmission (78). Such realities violate
the assumptions of the Wright–Fisher model and complicate in-
ference from genetic data. These peculiarities of the malaria life-
cycle may skew the allele-frequency spectrum toward increased
singletons, even at neutral sites, leading to quantitatively or even
qualitatively inappropriate demographic conclusions (79). However,
our demographic conclusions are supported by epidemiologic ob-
servation as well as by the results of other population genetic studies
(6, 13). Because extensive recognized and unrecognized paralogous
families in the P. vivax genome present significant mapping and
variant-calling challenges, we curated our data carefully, performing
extensive tests to determine the best alignment, filtering, and vari-
ant-calling approaches. In addition, none of our samples underwent
hybrid selection, giving us greater confidence in the quantitative
accuracy of calls in mixed infections and structural variants (80, 81).
In summary, we present evidence that sympatric P. vivax and
P. falciparum populations in Cambodia have responded in sub-
stantively different ways to the intense selective pressure imposed by
the recent artemisinin-resistance containment campaign and na-
tional antimalarial drug policies. Although P. falciparum has expe-
rienced population splitting, the P. vivax population remains
admixed, with strong growth, high genetic diversity, and frequent
polyclonal infections. These findings match epidemiologic obser-
vations of relative P. vivax resilience to current control measures.
Our comparative genomic analysis hints at the mechanisms behind
these different responses. Although we found that both P. vivax and
P. falciparum have experienced selective sweeps around known or
putative antimalarial-resistance genes, the strongest signatures of
directional selection in P. vivax occur near genes involved in tran-
scriptional regulation. These findings highlight important differ-
ences between P. vivax and P. falciparum biology that are relevant to
the direction of future malaria elimination efforts. P. vivax elimi-
nation will require a deeper understanding of the ways in which this
species exerts transcriptional control. A clearer picture of P. vivax
adaptive mechanisms will guide drug and vaccine strategies that
target early gametocytogenesis, hypnozoite biology, and the next
generation of drug resistance.
Materials and Methods
Sample Collection. Clinical isolates were collected between 2009 and 2013 by
the Armed Forces Research Institute of Medical Sciences in three Cambodian
provinces, Oddar Meanchey, Battâmbâng, and Kâmpôt (Fig. S1). Uncompli-
cated P. vivax or P. falciparum malaria patients presenting to study-site
clinics gave written informed consent for their participation in this study.
Study staff collected and leukodepleted venous blood and administered
treatment in accordance with Cambodian National Malaria Control Program
guidelines. Molecular studies were approved by the Institutional Review
Board at the University of North Carolina, the Walter Reed Army Institute of
Research Institutional Review Board, and the Cambodian National Ethical
Committee for Health Research. Additional details of the participants
are included in SI Materials and Methods, SI Participant Characteristics and
Table S8.
P. vivax and P. falciparum Sample Sequencing. For P. vivax, whole blood was
leukodepleted using Plasmodipur filters (Euro-Diagnostica). The ratio of
parasite DNA to host DNA was determined using a quantitative PCR (qPCR)
assay, and isolates with ≥20% P. vivax DNA were sequenced (82). Clinical
isolates with high plasmodium:human DNA content were sequenced on the
HiSeq 2000 or HiSeq 2500 sequencing system (Illumina) using 100- or 125-bp
paired-end chemistry. Data are available at the Sequence Read Archive, and
accession numbers are listed in Table S9. For P. falciparum, data from pre-
viously reported isolates as well as from two previously unidentified isolates
were used and reanalyzed in this study to allow comparable analysis
methods between species.
Sequence Analysis. Sequence reads were aligned to the P. falciparum 3D7 (v3)
and P. vivax Sal1 (v3) genomes using bwa mem, which allows a hybrid end-
to-end and local alignment approach (83). To increase sensitivity through
hypervariable regions, we raised the base-match bonus (A = 2) and the clip
penalty for local alignment (L = 15). PCR and optical duplicates were re-
moved from alignments using the Picard Tools MarkDuplicates utility, and
local realignment of highly entropic regions was performed using the GATK
IndelRealigner utility (broadinstitute.github.io/picard/). Isolates with fivefold
coverage at ≥80% of the genome and ≥90% of genes in the case of P. vivax
and with ≥60% of the genome and ≥90% of genes in the case of P. falciparum
were considered for variant calling and further analyses.
Variant calling for both species is described in SI Materials and Methods, SI
Sequencing Sympatric P. vivax and P. falciparum Populations. Variants were
called for each species independently but jointly for all samples using the
GATK UnifiedGenotyper (84, 85). Additional details of sequencing and bio-
informatic analysis are provided in SI Materials and Methods, SI Sequencing
Sympatric P. vivax and P. falciparum Populations.
Within-Host Diversity. To test whether infections were monoclonal or poly-
clonal, we used the FWS statistic (86, 87). To enable direct FWS comparisons
between P. falciparum and P. vivax isolates, which had different numbers of
loci, we bootstrapped each calculation 1,000 times, randomly selecting 5,000
variable sites for each isolate and each replicate. The maximum and mini-
mum FWS bootstrap values were identified to provide a generous upper and
lower confidence interval for each FWS point estimate. Additionally, P. vivax












isolates were screened for MOI using ultra-deep sequencing of the highly
polymorphic pvmsp1 locus (60). This screening was performed using the Ion
Torrent platform, and the reads for each individual were clustered using
SeekDeep, an iterative clustering algorithm (baileylab.umassmed.edu/Seek-
Deep/). Experimental procedures were performed as previously described
(60). For the purposes of the present study, a sample was deemed multi-
clonal if a minor clone existed at ≥10% read frequency.
Population Structure and Demographic Inferences.We determined population
substructuring using PCA, and cluster assignments were determined using a
nonparametric k-means approach. PCA was calculated using adegenet (19).
Five one-population demographic scenarios were fit to the observed site-
frequency spectra at synonymous sites in both the P. vivax and P. falciparum
populations (20). For each model, 100 independent runs were performed for
each dataset. Interrun parameter values were compared to assess model
convergence, and the iteration with the highest log-likelihood was selected.
Details pertaining to the models and parameter space explored are available
in SI Materials and Methods, SI Demographic Modeling Using a Diffusion
Approximation Paradigm.
Assessment of Tajima’s D. Gene loci with extreme high and low Tajima’s D
were identified for both P. vivax and P. falciparum, excluding genes from
highly paralogous families and in chromosomal telomeres (80). Nonexcluded
genes were simulated for corresponding Tajima’s D values using the R
package coala, a wrapper forms (88, 89). Inferred parameters for the best-fit
one-population demographic scenario for the P. falciparum ancestral-like
population, the entire P. vivax population, and the P. vivax monoclonal
population were used to parameterize coalescent simulations. Mutation
rates per gene were determined from gene length and the calculated ge-
nome mutation rate, because the mutation rate per gene considered in the
ms model is proportional to gene length (26). From these simulations, we
established a null distribution of Tajima’s D values for both P. vivax pop-
ulations and for the P. falciparum ancestral-like population to aid in iden-
tifying genes under unexpectedly strong balancing or directional selection.
Genes identified in the first and 99th percentile of the observed Tajima’s D
distribution for each of the three populations were investigated with
the GO analysis tool from PlasmoDB. Genes with a Bonferroni-corrected
P value <0.05 were considered significant by the GO analysis.
Haplotypic Scans of Positive Selection. Because there is as yet no fine-scale
map of recombination for the P. vivax genome, we initially sought a map-
independent haplotype-based approach. nSL, a modification of iHS, obviates
the need for a genetic map, reduces its dependence on recombination and
demographic events, and may afford increased sensitivity to detect soft se-
lective sweeps (23). This statistic has proved sensitive in identifying selection
in other nonmodel organisms (90). As a secondary test, we constructed re-
combination maps using LDhat interval and performed the iHS haplotype-
based test for directional selection (91, 92). iHS was calculated using iHH0/iHH1,
in which the subscripts 0 and 1 denote alleles, agnostic to ancestral or
derived status. For both nSL and iHS, because of the lack of outgroup se-
quences, we discarded the sign. We plotted iHS and nSL scores that
were normalized according to allele frequency bins. For selected intervals,
EHH was calculated for the selected and unselected allele. These three
haplotype-based tests for selection were performed using the program
selscan (93).
Copy Number Analysis.We identified CNVs using a tailored two-step approach
for identifying segmental duplications using a custom search approach tuned
to the AT-rich genome of Plasmodium sp. followed by a probabilistic
framework for detecting variants that incorporates multiple types of evi-
dence (SI Materials and Methods, SI CNV in P. vivax and P. falciparum). A
subset of P. falciparum md1 CNVs was confirmed using qPCR as described
previously (1, 94).
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